Science Explorer Back to mapMap
Discussion
Institution · Contraception Research and Development

Most cited papers from Contraception Research and Development

Contraception Research and Development

What are the most cited papers from Contraception Research and Development?

The most cited paper from Contraception Research and Development is "Progesterone implants enhance SIV vaginal transmission and early virus load" (Preston A. Marx, Alexander I. Spira, Agegnehu Gettie et al., 1996), with 466 citations. Next come "Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission" (441) and "Diabetes Trends Among Delivery Hospitalizations in the U.S., 1994–2004" (279).

Showing 50 of 60 papers. Every paper with more than 53 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Progesterone implants enhance SIV vaginal transmission and early virus load Preston A. Marx, Alexander I. Spira, Agegnehu Gettie et al. · Nature Medicine Oct 1996 466
2 Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission Lut Van Damme, Roshini Govinden, Florence Maureen Mirembe et al. · New England Journal of Medicine 30 Jul 2008 441
3 Diabetes Trends Among Delivery Hospitalizations in the U.S., 1994–2004 Sandra S. Albrecht, Elena V. Kuklina, Pooja Bansil et al. · Diabetes Care Open access 12 Jan 2010 279
4 Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities Vibhuti Agrahari, Vibhuti Agrahari, Vivek Agrahari et al. · Drug Discovery Today 31 Jan 2018 251
5 Extracellular Microvesicles as New Industrial Therapeutic Frontiers Vivek Kumar Agrahari, Vibhuti Agrahari, Pierre‐Alain Burnouf et al. · Trends in biotechnology Review 9 Jan 2019 217
6 Microbicide drug candidates to prevent HIV infection Jan Balzarini, Lut Van Damme · The Lancet Open access 16 Feb 2007 184
7 In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide Lisa Cencia Rohan, Bernard J. Moncla, Ratiya Pamela Kunjara Na Ayudhya et al. · PLoS ONE Open access 18 Feb 2010 184
8 In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials Deborah Tien, Roger L. Schnaare, Feirong Kang et al. · AIDS Research and Human Retroviruses Oct 2005 180
9 Postplacental or Delayed Insertion of the Levonorgestrel Intrauterine Device After Vaginal Delivery Beatrice A. Chen, Matthew F. Reeves, Jennifer L. Hayes et al. · Obstetrics and Gynecology Open access 23 Oct 2010 178
10 Intelligent micro-/nanorobots as drug and cell carrier devices for biomedical therapeutic advancement: Promising development opportunities and translational challenges Vibhuti Agrahari, Vibhuti Agrahari, Vivek Agrahari et al. · Biomaterials 30 May 2020 145
11 Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men Hermann M. Behre, Michael Zitzmann, Richard A. Anderson et al. · The Journal of Clinical Endocrinology & Metabolism Open access 27 Oct 2016 142
12 Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor Yanzuo Chen, Wei Zhang, Yukun Huang et al. · International Journal of Pharmaceutics 18 Apr 2015 138
13 RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate Peter A. Anton, Ross Cranston, Angela D. M. Kashuba et al. · AIDS Research and Human Retroviruses Open access 4 Sep 2012 135
14 Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation Thierry Burnouf, Vibhuti Agrahari, Vivek Kumar Agrahari · International Journal of Nanomedicine Open access Nov 2019 130
15 Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition Andrea Ries Thurman, Gustavo F. Doncel · American Journal of Reproductive Immunology 30 Jul 2010 121
16 The effect of one injection of Depo-Provera® on the human vaginal epithelium and cervical ectopy Christine K. Mauck, Marianne M. Callahan, Jay M. Baker et al. · Contraception Jul 1999 119
17 Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets Sanjay Garg, David Goldman, Markus Krumme et al. · Antiviral Research 24 Nov 2010 113
18 The Tablets, Ring, Injections as Options ( TRIO ) study: what young African women chose and used for future HIV and pregnancy prevention Ariane van der Straten, Kawango E. Agot, Khatija Ahmed et al. · Journal of the International AIDS Society Open access Mar 2018 112
19 Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential Vibhuti Agrahari, Vibhuti Agrahari, Pierre‐Alain Burnouf et al. · Advanced Drug Delivery Reviews Review 22 Feb 2019 111
20 Cervical Inflammation and Immunity Associated With Hormonal Contraception, Pregnancy, and HIV-1 Seroconversion CHARLES S. MORRISON, Raina Nakova Fichorova, Chris Mauck et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 10 Jan 2014 105
21 Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy Justin T. Clark, Meredith R. Clark, Namdev B. Shelke et al. · PLoS ONE Open access 5 Mar 2014 101
22 A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis Todd J. Johnson, Meredith R. Clark, Theodore H. Albright et al. · Antimicrobial Agents and Chemotherapy Open access 25 Sep 2012 101
23 An Intravaginal Ring for the Simultaneous Delivery of Multiple Drugs Marc M. Baum, Irina Butkyavichene, Joshua Gilman et al. · Journal of Pharmaceutical Sciences Open access 22 May 2012 99
24 Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity Andrea Ries Thurman, Thomas Kimble, Betsy C. Herold et al. · AIDS Research and Human Retroviruses Open access 23 Jul 2015 99
25 Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial Sinéad Delany‐Moretlwe et al. · The Lancet Infectious Diseases 24 Oct 2018 97
26 A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel Jill L. Schwartz, Wes Rountree, Angela D. M. Kashuba et al. · PLoS ONE Open access 19 Oct 2011 97
27 Development and Characterization of Bioadhesive Vaginal Films of Sodium Polystyrene Sulfonate (PSS), a Novel Contraceptive Antimicrobial Agent Sanjay Garg, Kavita Vermani, Alka B. Garg et al. · Pharmaceutical Research Apr 2005 96
28 Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study Christine K. Mauck, Debra H. Weiner, Susan Aucott Ballagh et al. · Contraception Dec 2001 92
29 Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines Kevin J. Whaley, Justin S. Hanes, Robin J. Shattock et al. · Antiviral Research 24 Nov 2010 88
30 Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring John A. Moss, Amanda M. D. Malone, Thomas J. Smith et al. · Antimicrobial Agents and Chemotherapy Open access 30 Nov 2011 88
31 Pharmacokinetic studies of quinidine in patients with arrhythmias. Kenneth A. Conrad, Barry Molk, Charles A. Chidsey · Circulation Open access 1977 87
32 Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study Jill L. Schwartz, Christine K. Mauck, Jaim-Jou Lai et al. · Contraception Open access 5 May 2006 85
33 First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy Peter A. Anton, Terry Saunders, Julie E. Elliott et al. · PLoS ONE Open access 28 Sep 2011 84
34 The utilization of humanized mouse models for the study of human retroviral infections Rachel Van Duyne, Caitlin Pedati, Irene Guendel et al. · Retrovirology Open access 12 Aug 2009 83
35 10th Summit Meeting Consensus: Recommendations for Regulatory Approval for Hormonal Male Contraception Pertti Aaltonen et al. · Journal of Andrology 27 Apr 2007 81
36 Recommendations for the clinical development of topical microbicides: an update Christine K. Mauck, Zeda Rosenberg, Lut Van Damme · AIDS May 2001 76
37 Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women Wafaa M. El-Sadr, Kenneth Hugh Mayer, Lisa Maslankowski et al. · AIDS 11 May 2006 76
38 Reformulated tenofovir gel for use as a dual compartment microbicide Charlene S. Dezzutti, Lisa Cencia Rohan, Lin Wang et al. · Journal of Antimicrobial Chemotherapy Open access 11 May 2012 75
39 Advances and applications of block-copolymer-based nanoformulations Vibhuti Agrahari, Vibhuti Agrahari, Vivek Agrahari et al. · Drug Discovery Today 18 Mar 2018 74
40 The Effect of Highly Active Antiretroviral Therapy on Human Papillomavirus Clearance and Cervical Cytology Pangaja Paramsothy, Denise J. Jamieson, Charles M. Heilig et al. · Obstetrics and Gynecology 2009 74
41 Vulvar, Vaginal, and Perianal Intraepithelial Neoplasia in Women With or at Risk for Human Immunodeficiency Virus Denise J. Jamieson, Pangaja Paramsothy, Susan Cu‐Uvin et al. · Obstetrics and Gynecology May 2006 73
42 Leukemia Inhibitory Factor, Leukemia Inhibitory Factor Receptor, and Glycoprotein 130 in Rhesus Monkey Uterus During Menstrual Cycle and Early Pregnancy1 Zhan‐Peng Yue, Zeng‐Ming Yang, Peng Wei et al. · Biology of Reproduction Aug 2000 72
43 The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception Raina Nakova Fichorova, Pai‐Lien Chen, CHARLES S. MORRISON et al. · mBio Open access 2 Sep 2015 71
44 Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception Cristián Jesam, A.M. Salvatierra, Jeffery L. Schwartz et al. · Human Reproduction 19 Nov 2009 69
45 Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir Muneeb Mohideen, Elias Quijano, Eric J. Song et al. · Biomaterials Open access 15 Aug 2017 68
46 Tenofovir-Based Preexposure Prophylaxis for HIV Infection Among African Women Jeanne Marisa Marrazzo et al. · Obstetrical & Gynecological Survey Jul 2015 67
47 Mucosal effects of tenofovir 1% gel Florian Hladik, Adam Burgener, Lamar Ballweber et al. · eLife Open access 3 Feb 2015 67
48 A Hot-Melt Extruded Intravaginal Ring for the Sustained Delivery of the Antiretroviral Microbicide UC781 Meredith R. Clark, Todd J. Johnson, R. Tyler McCabe et al. · Journal of Pharmaceutical Sciences 5 Oct 2011 67
49 Fourteen-day safety and acceptability study of the universal placebo gel Jill L. Schwartz, Susan Aucott Ballagh, Cynthia Kwok et al. · Contraception 26 Oct 2006 65
50 Delay of Ovulation by Meloxicam in Healthy Cycling Volunteers: A Placebo‐Controlled, Double‐blind, Crossover Study Majed Bata, Muataz Q. Al-Ramahi, Abdulazim S. Salhab et al. · The Journal of Clinical Pharmacology 19 Jul 2006 64

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.